Cargando…
Patient-Reported Outcomes, Health-Related Quality of Life, and Clinical Outcomes for Urothelial Cancer Patients Receiving Chemo- or Immunotherapy: A Real-Life Experience
Patients with urothelial cell carcinoma (UCC) often have comorbidities, which cause trouble for the completion of oncological treatment, and little is known about their quality of life (QoL). The aim of the present study was to obtain and describe patient-reported outcomes (PRO) and QoL data from UC...
Autores principales: | Taarnhøj, Gry Assam, Lindberg, Henriette, Johansen, Christoffer, Pappot, Helle |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8123186/ https://www.ncbi.nlm.nih.gov/pubmed/33923176 http://dx.doi.org/10.3390/jcm10091852 |
Ejemplares similares
-
Patient-reported outcomes item selection for bladder cancer patients in chemo- or immunotherapy
por: Taarnhøj, Gry Assam, et al.
Publicado: (2019) -
Patient reported symptoms associated with quality of life during chemo‐ or immunotherapy for bladder cancer patients with advanced disease
por: Taarnhøj, Gry A., et al.
Publicado: (2020) -
Electronic reporting of patient-reported outcomes in a fragile and comorbid population during cancer therapy – a feasibility study
por: Taarnhøj, Gry Assam, et al.
Publicado: (2020) -
The iBLAD study: patient-reported outcomes in bladder cancer during oncological treatment: a multicenter national randomized controlled trial
por: Taarnhøj, Gry Assam, et al.
Publicado: (2023) -
Quality of life in bladder cancer patients receiving medical oncological treatment; a systematic review of the literature
por: Taarnhøj, G. A., et al.
Publicado: (2019)